Results 131 to 140 of about 93,748 (310)

Effects of Changes in Metabolic Syndrome Status on Cognitive Function: A 10‐Year Study in a Middle‐Aged Population

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT The long‐term cumulative impact of metabolic syndrome (MS) on cognitive decline remains uncertain. This study investigated how changes in MS status over 10 years relate to cognition and whether sex modifies this relationship. A total of 766 participants (mean baseline age: 54 years) from the Kaohsiung Atherosclerosis Longitudinal Study were ...
Kelly Lim, Meng‐Ni Wu, Wei‐Chia Tsao, Wei‐Hao Lin, Suh‐Hang Hank Juo, Cheng‐Sheng Chen, Hsiu‐Fen Lin   +6 more
wiley   +1 more source

Choosing the right antihypertensive drug to avoid intradialytic hypotension. [PDF]

Clin Kidney J
Zoccali C, Tripepi G, Mallamaci F, Usvyat LS, Maddux FW, Stuard S.   +5 more
europepmc   +1 more source

Adverse drug reactions induced by antihypertensive agents [PDF]

, 2020
Reshma Elizabeth Raju, Arshi Hanif
openalex  

Metabolic Dysfunction‐Associated Steatotic Liver Disease After Hepatitis C Virus Cure

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Hepatitis C virus (HCV) infection is an infectious disease carrying a high risk of metabolic disorders. Chronic HCV (CHC) patients can possess extrahepatic manifestations such as diabetes, steatotic liver disease (SLD), and other metabolic alterations.
Chung‐Feng Huang, Jee‐Fu Huang, Ming‐Lung Yu, Wan‐Long Chuang   +3 more
wiley   +1 more source

Trends in antihypertensive drug utilization in British Columbia, 2004-2019: a descriptive study. [PDF]

CMAJ Open, 2023
Kim JD, Fisher A, Dormuth CR.
europepmc   +1 more source

Constructing a Personalized Treatment Rule for Initial Therapy in Early Parkinson's Disease

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, EarlyView.
ABSTRACT Background Dopaminergic therapies such as levodopa and dopamine receptor agonists (DRA) improve motor function in people with Parkinson's disease. These therapies are also linked to the advent of motor complications such as dyskinesias and wearing‐off episodes.
Zachary P. Brehm, Ruth B. Schneider, Charles S. Venuto, Greta Smith, Cuong Tuan Pham, Michael P. McDermott, Ashkan Ertefaie   +6 more
wiley   +1 more source

Frequency of Antihypertensive Drug Classes and Single-Pill Combinations in Obese Patients: An 8-Year Retrospective Study. [PDF]

J Clin Hypertens (Greenwich)
Moczulska B, Osowiecka K, Gromadziński L, Majewska M.   +3 more
europepmc   +1 more source

Antihypertensive drugs and anæsthesia [PDF]

Anaesthesia, 1966
openaire   +2 more sources

Long‐term remission in gout: Challenges and future opportunities

Rheumatology &Autoimmunity, EarlyView.
Prolonged hyperuricemia is a major risk factor for gout, which is now regarded as a curable disease. Awareness of the various factors that can trigger gout flares is essential for their prevention. An important determinant of treatment decisions and long‐term follow‐up is the quality of the clinician–patient relationship. The “treat‐to‐target” approach
Patapong Towiwat, Zhanguo Li
wiley   +1 more source

Impact of antihypertensive drug classes on cardiovascular outcomes: insights from the STEP study. [PDF]

BMC Med
Peng X, Olsen MH, Pareek M, Bai J, Liu Y, Song Q, Cai J.   +6 more
europepmc   +1 more source